Timing: Smaller, split doses earlier in the day are common to avoid insomnia or stimulantlike effects late at night
For this reason, the authors did not incorporate specific biomarker assessments commonly used in adolescent-focused trials, such as lipid profiles, CRP, or other cardiometabolic indicators beyond HbA1c and BMI
Therefore, we carried out a cross-sectional study based on hospital patients with T2DM to explore the effects of short-chain acylcarnitines on CVD in T2DM patients
Consult your physician or a registered dietitian for personalized recommendations
251 Although the phase III FLOURISH trial of RT100 was originally planned for 2019, it was withdrawn because of business adjustments
Your exact maintenance dose will be different depending on the active ingredient